New catheter offers hope for heart failure patients resistant to diuretics
NCT ID NCT05876078
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a new device called the Doraya Catheter in 25 hospitalized heart failure patients whose bodies were not responding well to standard water pills (diuretics). The goal was to see if the catheter could safely and effectively remove excess fluid. The study focused on safety and urine output, not on curing heart failure.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE DECOMPENSATED HEART FAILURE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
A.O.U Pisana Cisanello
Pisa, Italy
-
CINRE, s.r.o.
Bratislava, Slovakia
-
Heartcenter Dresden
Dresden, Germany
-
Hospital Clínico Universitario de Valencia
Valencia, Spain
-
Hospital clinic de Barcelona
Barcelona, 08036, Spain
-
Klinikum Fürth
Fürth, Germany
-
Mikulicz-Radecki University Teaching Hospital in Wrocław
Wroclaw, 50-368, Poland
-
SUSCCH
Banská Bystrica, Slovakia
-
UKSH Universitäres Herzzentrum Lübeck
Lübeck, Germany
-
Universitätsmedizin der Johannes Gutenberg-Universität Mainz
Mainz, Germany
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Are heart failure patients taking their meds? a urine test at the ER aims to find out
- Can common heart drugs stay safe during a crisis? a trial investigates
- Heart failure fluid removal device trial halted early
- Massive new registry aims to unlock secrets of deadly heart shock
- Heart failure study aims to tailor treatments using biomarkers
- New device automates fluid removal in heart failure – could it be a game changer?